Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DRAXINP1 (dorsal inhibitory axon guidance protein pseudogene 1) is a human pseudogene located on chromosome Xp22.31[1]. Pseudogenes are genetic elements resembling known genes but rendered nonfunctional by mutations or other defects. Unlike their protein-coding relatives, pseudogenes like DRAXINP1 do not encode proteins and are generally believed to be transcriptionally inactive, although in some cases pseudogenes can regulate the expression of their parental genes or other genes through RNA-level mechanisms such as acting as competitive endogenous RNAs or producing small interfering RNAs[2][3][4]. DRAXINP1 is not known to be involved in any disease or biological process, nor is it recognized as a therapeutic, diagnostic, or prognostic molecular target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dorsal inhibitory axon guidance protein pseudogene 1 (DRAXINP1).